Background: Older patients hospitalized with acute decompensated heart failure (ADHF) have marked functional impairments, which may contribute to their delayed and incomplete recovery and persistently poor outcomes. However, whether impairment severity differs by race and sex is unknown. Methods: REHAB-HF trial participants (≥60 years) were assessed just before discharge home from ADHF hospitalization. Physical function [Short Physical Performance Battery; 6-min walk distance (6MWD)], frailty (Fried criteria), cognition [Montreal Cognitive Assessment (MoCA)], quality-of-life [Kansas City Cardiomyopathy Questionnaire, Short-Form-12, EuroQol-5D-5L], and depression [Geriatric Depression Scale (GDS)] were examined by race and sex.Results: This prespecified subgroup cross-sectional analysis included 337 older adults (52% female, 50% Black). Black participants were on average younger than White participants (70.3 ± 7.2 vs. 74.7 ± 8.3 years). After age, body mass index, ejection fraction, comorbidity, and education adjustment, and impairments were similarly common and severe across groups except: Black male and Black and White female participants had more severely impaired walking
Rider, BC, Conger, SA, Ditzenberger, GL, Besteman, SS, Bouret, CM, and Coughlin, AM. Examining the accuracy of the Polar A360 monitor. J Strength Cond Res 35(8): 2165–2169, 2021—The purpose of this study was to determine the accuracy of the Polar A360 heart rate (HR) monitor during periods of rest, walking/running, and active/passive recovery from exercise. Thirty collegiate athletes (women n = 15 and men n = 15) wore an A360 monitor and a previously validated chest HR monitor (Polar RS400) that served as the criterion measurement across a range of resting and walking/running intensities. First, subjects rested in a supine, seated, and standing position. Next, each subject walked on a treadmill at 1.6 kilometers per hour (kph). Speed was increased by 1.6 kph every 2 minutes until volitional fatigue. Then, subjects walked at 4.8 kph followed by a seated recovery stage. Heart rate was recorded in 30-second increments. Total mean difference in HR readings, percent accuracy, and intraclass correlation coefficient (ICC) analysis established the level of agreement between devices. Bland-Altman plots and a regression were used to examine the agreement between devices. The A360 demonstrated a strong correlation with the RS400 (r 2 = 0.98) across time points. The analysis of variance with repeated measures indicated an overall significant difference (p < 0.001) between devices. The A360 significantly underestimated HR during the 6.4-kph speed only (p < 0.05) (effect size 0.26). The greatest percent accuracy occurred during rest (91%) and recovery (90%). An ICC of 0.98 (SEM: 0.35) demonstrates a strong level of agreement between devices. The A360 is accurate at rest and during various walking and running speeds and thus is a device that can be used with confidence by athletes for specific training purposes. Future research should examine accuracy during weight training and other sport-specific activities.
Background Muscle weakness and exercise intolerance contribute to reduced quality of life (QOL) in Barth syndrome (BTHS). Our group previously found that 12 weeks of resistance exercise training (RET) improved muscle strength, however, did not increase muscle (lean) mass or QOL in n = 3 young adults with BTHS. The overall objective of this pilot study was to examine the safety and effectiveness of RET plus daily protein supplementation (RET + protein) on muscle strength, skeletal muscle mass, exercise tolerance, cardiac function, and QOL in late adolescents/young adults with BTHS. Methods Participants with BTHS (n = 5, age 27 ± 7) performed 12 weeks of supervised RET (60 minutes per session, three sessions/week) and consumed 42 g/day of whey protein. Muscle strength, muscle mass, exercise capacity, cardiac function, and health‐related QOL were assessed pre‐post intervention. Results RET + protein was safe, increased muscle strength and quality of life, and tended to increase lean mass. Conclusions RET + protein appears safe, increases muscle strength and quality of life and tends to increase lean mass. Larger studies are needed to confirm these findings and to fully determine the effects of RET + protein in individuals with BTHS.
Apply it!• Gain a better understanding of the purpose of occlusion training, how to properly utilize it, and when to use it with your clients.• Understand the contraindications to occlusion training and know some of the possible health risks associated with it.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.